These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 35180322)
1. Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers. Teng F; Wang W; Zhang W; Qu J; Liu B; Chen J; Liu S; Li M; Chen W; Wei H Biopharm Drug Dispos; 2022 Aug; 43(4):119-129. PubMed ID: 35180322 [TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients. Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of Wuzhi Capsule on tacrolimus blood concentrations in liver transplant patients with different donor-recipient CYP3A5 genotypes. Kou K; Sun X; Li M; Li T; Hu Y; Li S; Lv G J Clin Pharm Ther; 2022 Feb; 47(2):200-210. PubMed ID: 34708436 [TBL] [Abstract][Full Text] [Related]
4. Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats. Wei H; Tao X; Di P; Yang Y; Li J; Qian X; Feng J; Chen W Drug Metab Dispos; 2013 Jul; 41(7):1398-403. PubMed ID: 23628674 [TBL] [Abstract][Full Text] [Related]
5. Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients. Cheng F; Li Q; Wang J; Zeng F; Zhang Y J Clin Pharm Ther; 2021 Dec; 46(6):1636-1649. PubMed ID: 34342024 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interactions between tacrolimus and Wuzhi capsule in liver transplant recipients: Genetic polymorphisms affect the drug interaction. Huang S; Song W; Jiang S; Li Y; Wang M; Yang N; Zhu H Chem Biol Interact; 2024 Mar; 391():110906. PubMed ID: 38340974 [TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetic study of tacrolimus and Qu J; Bian R; Liu B; Chen J; Zhai J; Teng F; Guo W; Wei H Front Pharmacol; 2022; 13():956166. PubMed ID: 36188616 [No Abstract] [Full Text] [Related]
8. Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients. Yan L; Yang ZQ; Shi YY; Ren J; Yang CL; Wan ZL; Bai YJ; Luo LM; Wang LL; Li Y Ann Transplant; 2019 Nov; 24():594-604. PubMed ID: 31712547 [TBL] [Abstract][Full Text] [Related]
9. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule. Chen X; Wang D; Xu H; Li Z J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126 [TBL] [Abstract][Full Text] [Related]
10. Wuzhi Tablet ( Li J; Chen S; Qin X; Fu Q; Bi H; Zhang Y; Wang X; Liu L; Wang C; Huang M Drug Metab Dispos; 2017 Nov; 45(11):1114-1119. PubMed ID: 28864749 [TBL] [Abstract][Full Text] [Related]
11. Effect of drug combination on tacrolimus target dose in renal transplant patients with different Zhang SF; Tang BH; Wei AH; Du Y; Guan ZW; Li Y Xenobiotica; 2022 Mar; 52(3):312-321. PubMed ID: 35395919 [TBL] [Abstract][Full Text] [Related]
12. Validation of an LC-MS/MS method for quantitative analysis of the 5 bioactive components of Wuzhi capsule in human plasma samples. Wei H; Miao H; Yun Y; Li J; Qian X; Wu R; Chen W Ther Drug Monit; 2014 Dec; 36(6):781-8. PubMed ID: 25392942 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patients. Teng F; Zhang W; Wang W; Chen J; Liu S; Li M; Li L; Guo W; Wei H Biopharm Drug Dispos; 2022 Apr; 43(2):76-85. PubMed ID: 35220592 [TBL] [Abstract][Full Text] [Related]
14. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule. Chen X; Wang DD; Xu H; Li ZP Xenobiotica; 2020 May; 50(5):606-613. PubMed ID: 31530218 [TBL] [Abstract][Full Text] [Related]
15. Clinical observation on the effect of Wuzhi soft capsule on FK506 concentration in membranous nephropathy patients. Zhang Z; Lu X; Dong L; Ma J; Fan X Medicine (Baltimore); 2019 Nov; 98(48):e18150. PubMed ID: 31770256 [TBL] [Abstract][Full Text] [Related]
16. Co-administration of Wuzhi tablet (Schisandra sphenanthera extract) alters tacrolimus pharmacokinetics in a dose- and time-dependent manner in rats. Qin XL; Li JL; Wang SH; Chen X; Huang M; Bi HC J Ethnopharmacol; 2020 Dec; 263():113233. PubMed ID: 32768638 [TBL] [Abstract][Full Text] [Related]
17. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Haufroid V; Mourad M; Van Kerckhove V; Wawrzyniak J; De Meyer M; Eddour DC; Malaise J; Lison D; Squifflet JP; Wallemacq P Pharmacogenetics; 2004 Mar; 14(3):147-54. PubMed ID: 15167702 [TBL] [Abstract][Full Text] [Related]
18. Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography-tandem mass spectrometry. Zhu J; Zhong L; Song Y; Ding H; Xin W; Xu G; Fang L J Sep Sci; 2024 Mar; 47(5):e2300923. PubMed ID: 38466147 [TBL] [Abstract][Full Text] [Related]
19. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. Qin XL; Chen X; Zhong GP; Fan XM; Wang Y; Xue XP; Wang Y; Huang M; Bi HC Phytomedicine; 2014 Apr; 21(5):766-72. PubMed ID: 24462213 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients. Du Y; Song W; Xiong X; Ge W; Zhu H Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]